Literature DB >> 1915172

Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis.

A Arlazoroff1, B Roitberg, E Werber, R Shidlo, V M Berginer.   

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare hereditary disease characterized by xanthomata of tendons, osteoporosis, cataracts, cerebellar ataxia, spastic paresis, and dementia. Though electroencephalographic (EEG) abnormalities are frequent in CTX, epileptic seizures have not been recognized as a major feature. A CTX patient is reported who presented with a generalized epileptic seizure and was evaluated with EEG and neuropsychological testing. Epilepsy should be considered a feature of CTX, and CTX considered as a possible, though rare, cause of symptomatic seizures.

Entities:  

Mesh:

Year:  1991        PMID: 1915172     DOI: 10.1111/j.1528-1157.1991.tb04705.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.

Authors:  A Mignarri; S Rossi; M Ballerini; G N Gallus; M Del Puppo; P Galluzzi; A Federico; M T Dotti
Journal:  J Neurol       Date:  2010-11-21       Impact factor: 4.849

2.  Cerebrotendinous xanthomatosis: a rare genetic disorder.

Authors:  Rohan Arjun Bhojwani; Rajashree Khot
Journal:  BMJ Case Rep       Date:  2011-09-05

3.  Therapies for ataxias.

Authors:  Laurence Martineau; Anne Noreau; Nicolas Dupré
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

4.  Progressive Myoclonic Epilepsy'-like presentation of Cerebrotendinous Xanthomatosis in an Indian Family with A Novel C.646+1G>A Splice Site Mutation.

Authors:  Karan M Desai; Piyush Kumar; Parthvi S Ravat; Sangeeta H Ravat; Neeraj Jain; Shruti Agrawal; Rahil Ansari
Journal:  Epilepsy Behav Rep       Date:  2020-11-16

5.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.